TABLE 2.

List of orofacial adverse effects of BNT162b2 (Pfizer‐BioNTech) and mRNA‐1273 (Moderna) vaccines as reported in the information to healthcare providers ^a

Vaccine	Country/region	Reported orofacial adverse effects
BNT162b2	United States	Bell's palsy (facial paralysis)
mRNA‐1273	United States	Bell's palsy, facial swelling (vaccine recipients with a history of injection of dermatological filler)
BNT162b2	Canada	None
mRNA‐1273	Canada	Facial swelling
BNT162b2	EU	Rare: acute peripheral facial paralysis
mRNA‐1273	EU	Rare: acute peripheral facial paralysis; facial swelling
BNT162b2	United Kingdom	Rare: acute peripheral facial paralysis
mRNA‐1273	United Kingdom	Rare: facial paralysis; swelling of the face (in patients who have had facial cosmetic injections)

^a Severe allergic reactions were reported for all drugs without explicitly reporting orofacial symptoms such as swelling of the face or tongue.